InvestorsHub Logo
Followers 21
Posts 2161
Boards Moderated 0
Alias Born 12/03/2016

Re: None

Thursday, 08/01/2024 12:10:29 AM

Thursday, August 01, 2024 12:10:29 AM

Post# of 387811
The DEA might reclassify cannabis, removing it from the list of schedule-1 drugs. This would enable the FDA to conduct medical research, and allow insurance companies to assist patients by lowering the overall cost of medical cannabis. This could be achieved through a co-pay system similar to what is used for prescription medications at pharmacies.

$MSOS $MRMD
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SPY News